SlideShare ist ein Scribd-Unternehmen logo
1 von 24
Downloaden Sie, um offline zu lesen
Role of Q.C & Q.A in Pharmaceutical IndustryRole of Q.C & Q.A in Pharmaceutical Industry
PresentedPresented ByBy
Rezowanul HaqueRezowanul Haque
PharmacistPharmacist
Daffodil Internation al UniversityDaffodil Internation al University
BangladeshBangladesh
QC Roles
Evaluation of quality throughout process:
Raw materials and API
Drug Product
Packaging components
Reassay
Retains
QC Responsibilities
Efficacy
Safety
Quality
Compliance
 FDA, MHRA, ICH
 USP, BP, EP, JP
Raw Materials
All Raw Materials are tested on site before use
Incoming identity
Full release testing
Includes Excipients, Capsules, API
Various techniques
Raman and IR Spectroscopy
Assay (HPLC and Titration)
Physical Tests
Packaging Components
All packaging components tested if in contact
with drug product
Bottles
Blister pack components
Cotton wool, Desiccants
Range of techniques
Appearance
Spectroscopy
Loss on Drying
Finished Product (Release)
Release into Clinic
Mainly 2 techniques
HPLC
Dissolution
Several tests
Assay
Content Uniformity
Dissolution
Finished Product (Reassay)
Scheduled reassessment of released drugs
Ensures continued efficacy
Same techniques as Release
HPLC, Dissolution
Reduced testing for reassay
Reassay schedule drug dependant
Comparators –manufacturers expiry
In house drugs –decided by formulator
Retains
 Sample of everything tested retained
 Enough for full testing in duplicate
 At label conditions
 Retain time determined by regulatory
guidelines
 Raw materials 12 Years
 Finished products 10 Years
 All unsealed finished products inspected
annually
Cleaning Verification
All manufacturing equipment cleaned
Subject Exposure Limit (SEL) set
SEL converted to a Residue Limit (RL)
Equipment swabbed
Tested using HPLC

Std concentration made to RL

Swab concentration must be lower than std
All surfaces must be validated
Future
Process Analytical Technology
Paperless laboratory
Explore new uses of analytical techniques
NIR
IMS
Quality Assurance
Thanks to all

Weitere ähnliche Inhalte

Was ist angesagt?

Lecture 3: QC and QA-International perspective of USA, WHO, ICH & India
Lecture 3: QC and QA-International perspective of USA, WHO, ICH & IndiaLecture 3: QC and QA-International perspective of USA, WHO, ICH & India
Lecture 3: QC and QA-International perspective of USA, WHO, ICH & IndiaSapan Shah
 
ICH Guidlines for stability studies
ICH Guidlines for stability studiesICH Guidlines for stability studies
ICH Guidlines for stability studiesVishnu Satpute
 
Analysis of raw materials
Analysis of raw materialsAnalysis of raw materials
Analysis of raw materialsSkAzizuddin1
 
Impurity profiling and degradent characterization {presented by shameer m.pha...
Impurity profiling and degradent characterization {presented by shameer m.pha...Impurity profiling and degradent characterization {presented by shameer m.pha...
Impurity profiling and degradent characterization {presented by shameer m.pha...ShameerAbid
 
Pharmaceutical preformulation and formulation
Pharmaceutical preformulation  and formulationPharmaceutical preformulation  and formulation
Pharmaceutical preformulation and formulationSuchandra03
 
Impurities ICH Q3 Guidelines Au Vivek Jain
Impurities ICH Q3 Guidelines Au Vivek JainImpurities ICH Q3 Guidelines Au Vivek Jain
Impurities ICH Q3 Guidelines Au Vivek JainVivek Jain
 
Training Session on Good Manufacturing Practices of the 21st Century
Training Session on Good Manufacturing Practices of the 21st CenturyTraining Session on Good Manufacturing Practices of the 21st Century
Training Session on Good Manufacturing Practices of the 21st CenturyObaid Ali / Roohi B. Obaid
 
Comparison of stability testing requirements of ich with other
Comparison of stability testing requirements of ich with otherComparison of stability testing requirements of ich with other
Comparison of stability testing requirements of ich with otherJun Brown
 
The pharmaceutical manufacturing principles - Quality Control
The pharmaceutical manufacturing principles - Quality ControlThe pharmaceutical manufacturing principles - Quality Control
The pharmaceutical manufacturing principles - Quality ControlInbarajAnandan
 
Preformulation formulation solid drug research
Preformulation formulation solid drug researchPreformulation formulation solid drug research
Preformulation formulation solid drug researchPharmaceutical Scientist
 

Was ist angesagt? (20)

Lecture 3: QC and QA-International perspective of USA, WHO, ICH & India
Lecture 3: QC and QA-International perspective of USA, WHO, ICH & IndiaLecture 3: QC and QA-International perspective of USA, WHO, ICH & India
Lecture 3: QC and QA-International perspective of USA, WHO, ICH & India
 
ICH Guidlines for stability studies
ICH Guidlines for stability studiesICH Guidlines for stability studies
ICH Guidlines for stability studies
 
ICH Q6A & ICH Q7
ICH Q6A & ICH Q7ICH Q6A & ICH Q7
ICH Q6A & ICH Q7
 
Q6 guidelines
Q6 guidelinesQ6 guidelines
Q6 guidelines
 
Analysis of raw materials
Analysis of raw materialsAnalysis of raw materials
Analysis of raw materials
 
Impurity profiling and degradent characterization {presented by shameer m.pha...
Impurity profiling and degradent characterization {presented by shameer m.pha...Impurity profiling and degradent characterization {presented by shameer m.pha...
Impurity profiling and degradent characterization {presented by shameer m.pha...
 
Qualityassurancecontrolinpharmaindustry
QualityassurancecontrolinpharmaindustryQualityassurancecontrolinpharmaindustry
Qualityassurancecontrolinpharmaindustry
 
Ich guidelines
Ich guidelinesIch guidelines
Ich guidelines
 
Pharmaceutical preformulation and formulation
Pharmaceutical preformulation  and formulationPharmaceutical preformulation  and formulation
Pharmaceutical preformulation and formulation
 
Impurities ICH Q3 Guidelines Au Vivek Jain
Impurities ICH Q3 Guidelines Au Vivek JainImpurities ICH Q3 Guidelines Au Vivek Jain
Impurities ICH Q3 Guidelines Au Vivek Jain
 
Training Session on Good Manufacturing Practices of the 21st Century
Training Session on Good Manufacturing Practices of the 21st CenturyTraining Session on Good Manufacturing Practices of the 21st Century
Training Session on Good Manufacturing Practices of the 21st Century
 
PQRS-CCK (ICH- Q1) March 2017
PQRS-CCK (ICH- Q1) March 2017PQRS-CCK (ICH- Q1) March 2017
PQRS-CCK (ICH- Q1) March 2017
 
K M Suleman
K M SulemanK M Suleman
K M Suleman
 
Ipqc presentation
Ipqc presentationIpqc presentation
Ipqc presentation
 
PHOTOSTABILITY TESTING SEM I SEMINAR
PHOTOSTABILITY TESTING SEM I SEMINARPHOTOSTABILITY TESTING SEM I SEMINAR
PHOTOSTABILITY TESTING SEM I SEMINAR
 
Stability studies
Stability studiesStability studies
Stability studies
 
Comparison of stability testing requirements of ich with other
Comparison of stability testing requirements of ich with otherComparison of stability testing requirements of ich with other
Comparison of stability testing requirements of ich with other
 
ICH Guidelines
ICH GuidelinesICH Guidelines
ICH Guidelines
 
The pharmaceutical manufacturing principles - Quality Control
The pharmaceutical manufacturing principles - Quality ControlThe pharmaceutical manufacturing principles - Quality Control
The pharmaceutical manufacturing principles - Quality Control
 
Preformulation formulation solid drug research
Preformulation formulation solid drug researchPreformulation formulation solid drug research
Preformulation formulation solid drug research
 

Andere mochten auch

1 Quality Assurance Presentation
1 Quality Assurance Presentation1 Quality Assurance Presentation
1 Quality Assurance Presentationguest337c19
 
In Process Quality Control System (IPQC) for Solid Dosages Form (Tablets)
In Process Quality Control System (IPQC) for Solid Dosages Form (Tablets)In Process Quality Control System (IPQC) for Solid Dosages Form (Tablets)
In Process Quality Control System (IPQC) for Solid Dosages Form (Tablets)Gaurav kumar
 

Andere mochten auch (6)

cGMP.
cGMP.cGMP.
cGMP.
 
Quality assurance
Quality assuranceQuality assurance
Quality assurance
 
1 Quality Assurance Presentation
1 Quality Assurance Presentation1 Quality Assurance Presentation
1 Quality Assurance Presentation
 
Quality Assurance & Control
Quality Assurance & ControlQuality Assurance & Control
Quality Assurance & Control
 
In Process Quality Control System (IPQC) for Solid Dosages Form (Tablets)
In Process Quality Control System (IPQC) for Solid Dosages Form (Tablets)In Process Quality Control System (IPQC) for Solid Dosages Form (Tablets)
In Process Quality Control System (IPQC) for Solid Dosages Form (Tablets)
 
QUALITY ASSURANCE
QUALITY ASSURANCEQUALITY ASSURANCE
QUALITY ASSURANCE
 

Ähnlich wie Role of QC and QA in Pharma Industry

Internnship report_Summer 2016_Pranav Attavar
Internnship report_Summer 2016_Pranav AttavarInternnship report_Summer 2016_Pranav Attavar
Internnship report_Summer 2016_Pranav AttavarPranav Attavar
 
Reference standards in Pharmaceutical Industries
Reference standards in Pharmaceutical IndustriesReference standards in Pharmaceutical Industries
Reference standards in Pharmaceutical Industriesbhavanavedantam
 
Process development
Process developmentProcess development
Process development9160676107
 
Bhavya Madhavan updated CV
Bhavya Madhavan updated CVBhavya Madhavan updated CV
Bhavya Madhavan updated CVBhavya Madhavan
 
Pharmacuetical Analysis lecture notes
Pharmacuetical Analysis  lecture notesPharmacuetical Analysis  lecture notes
Pharmacuetical Analysis lecture notesDenekeAlemayehu
 
biosimilar-intended copies--mohie.pdf
biosimilar-intended copies--mohie.pdfbiosimilar-intended copies--mohie.pdf
biosimilar-intended copies--mohie.pdfmohieeldien elsayed
 
biosimilar-intended copies--mohie.pdf
biosimilar-intended copies--mohie.pdfbiosimilar-intended copies--mohie.pdf
biosimilar-intended copies--mohie.pdfmohieeldien elsayed
 
DRUG STABILITY ppt.ppt
DRUG STABILITY ppt.pptDRUG STABILITY ppt.ppt
DRUG STABILITY ppt.pptrameshjanga11
 
WHOguidelinesforqualityassessmentofHerbaldrugs-R.pptx
WHOguidelinesforqualityassessmentofHerbaldrugs-R.pptxWHOguidelinesforqualityassessmentofHerbaldrugs-R.pptx
WHOguidelinesforqualityassessmentofHerbaldrugs-R.pptxPrasanthBalakrishnap
 
Ramanaidu CV
Ramanaidu CVRamanaidu CV
Ramanaidu CVRma Naidu
 
Specification: Test procedure and acceptance criteria
Specification: Test procedure and acceptance criteriaSpecification: Test procedure and acceptance criteria
Specification: Test procedure and acceptance criteriaDigeshPatel17
 
DDS DRUGS AND DOSAGE FORMS-2020.ppt
DDS DRUGS AND DOSAGE FORMS-2020.pptDDS DRUGS AND DOSAGE FORMS-2020.ppt
DDS DRUGS AND DOSAGE FORMS-2020.pptFakhrulAhsan2
 
Cv jun' 2018 (20 years exp.)
Cv  jun' 2018 (20 years exp.)Cv  jun' 2018 (20 years exp.)
Cv jun' 2018 (20 years exp.)Padala Reddy
 
product formulation and development
product formulation and developmentproduct formulation and development
product formulation and developmentkalyaniArisettti
 
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...Dr K SUDHEER KUMAR KANDIBANDA
 

Ähnlich wie Role of QC and QA in Pharma Industry (20)

Internnship report_Summer 2016_Pranav Attavar
Internnship report_Summer 2016_Pranav AttavarInternnship report_Summer 2016_Pranav Attavar
Internnship report_Summer 2016_Pranav Attavar
 
analsis1.pptx
analsis1.pptxanalsis1.pptx
analsis1.pptx
 
Reference standards in Pharmaceutical Industries
Reference standards in Pharmaceutical IndustriesReference standards in Pharmaceutical Industries
Reference standards in Pharmaceutical Industries
 
CCK Technical Group Session 1 - B
CCK Technical Group Session 1 - BCCK Technical Group Session 1 - B
CCK Technical Group Session 1 - B
 
Process development
Process developmentProcess development
Process development
 
Bhavya Madhavan updated CV
Bhavya Madhavan updated CVBhavya Madhavan updated CV
Bhavya Madhavan updated CV
 
Pharmacuetical Analysis lecture notes
Pharmacuetical Analysis  lecture notesPharmacuetical Analysis  lecture notes
Pharmacuetical Analysis lecture notes
 
biosimilar-intended copies--mohie.pdf
biosimilar-intended copies--mohie.pdfbiosimilar-intended copies--mohie.pdf
biosimilar-intended copies--mohie.pdf
 
biosimilar-intended copies--mohie.pdf
biosimilar-intended copies--mohie.pdfbiosimilar-intended copies--mohie.pdf
biosimilar-intended copies--mohie.pdf
 
DRUG STABILITY ppt.ppt
DRUG STABILITY ppt.pptDRUG STABILITY ppt.ppt
DRUG STABILITY ppt.ppt
 
WHOguidelinesforqualityassessmentofHerbaldrugs-R.pptx
WHOguidelinesforqualityassessmentofHerbaldrugs-R.pptxWHOguidelinesforqualityassessmentofHerbaldrugs-R.pptx
WHOguidelinesforqualityassessmentofHerbaldrugs-R.pptx
 
ANDA.pptx
ANDA.pptxANDA.pptx
ANDA.pptx
 
Ramanaidu CV
Ramanaidu CVRamanaidu CV
Ramanaidu CV
 
Monograph changes
Monograph changesMonograph changes
Monograph changes
 
Specification: Test procedure and acceptance criteria
Specification: Test procedure and acceptance criteriaSpecification: Test procedure and acceptance criteria
Specification: Test procedure and acceptance criteria
 
Diteba Research Laboratories Corporate Capabilities
Diteba Research Laboratories Corporate CapabilitiesDiteba Research Laboratories Corporate Capabilities
Diteba Research Laboratories Corporate Capabilities
 
DDS DRUGS AND DOSAGE FORMS-2020.ppt
DDS DRUGS AND DOSAGE FORMS-2020.pptDDS DRUGS AND DOSAGE FORMS-2020.ppt
DDS DRUGS AND DOSAGE FORMS-2020.ppt
 
Cv jun' 2018 (20 years exp.)
Cv  jun' 2018 (20 years exp.)Cv  jun' 2018 (20 years exp.)
Cv jun' 2018 (20 years exp.)
 
product formulation and development
product formulation and developmentproduct formulation and development
product formulation and development
 
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
 

Kürzlich hochgeladen

Understanding Post Production changes (PPC) in Clinical Data Management (CDM)...
Understanding Post Production changes (PPC) in Clinical Data Management (CDM)...Understanding Post Production changes (PPC) in Clinical Data Management (CDM)...
Understanding Post Production changes (PPC) in Clinical Data Management (CDM)...soumyapottola
 
Scootsy Overview Deck - Pan City Delivery
Scootsy Overview Deck - Pan City DeliveryScootsy Overview Deck - Pan City Delivery
Scootsy Overview Deck - Pan City Deliveryrishi338139
 
cse-csp batch4 review-1.1.pptx cyber security
cse-csp batch4 review-1.1.pptx cyber securitycse-csp batch4 review-1.1.pptx cyber security
cse-csp batch4 review-1.1.pptx cyber securitysandeepnani2260
 
Application of GIS in Landslide Disaster Response.pptx
Application of GIS in Landslide Disaster Response.pptxApplication of GIS in Landslide Disaster Response.pptx
Application of GIS in Landslide Disaster Response.pptxRoquia Salam
 
Don't Miss Out: Strategies for Making the Most of the Ethena DigitalOpportunity
Don't Miss Out: Strategies for Making the Most of the Ethena DigitalOpportunityDon't Miss Out: Strategies for Making the Most of the Ethena DigitalOpportunity
Don't Miss Out: Strategies for Making the Most of the Ethena DigitalOpportunityApp Ethena
 
Testing with Fewer Resources: Toward Adaptive Approaches for Cost-effective ...
Testing with Fewer Resources:  Toward Adaptive Approaches for Cost-effective ...Testing with Fewer Resources:  Toward Adaptive Approaches for Cost-effective ...
Testing with Fewer Resources: Toward Adaptive Approaches for Cost-effective ...Sebastiano Panichella
 
05.02 MMC - Assignment 4 - Image Attribution Lovepreet.pptx
05.02 MMC - Assignment 4 - Image Attribution Lovepreet.pptx05.02 MMC - Assignment 4 - Image Attribution Lovepreet.pptx
05.02 MMC - Assignment 4 - Image Attribution Lovepreet.pptxerickamwana1
 
Testing and Development Challenges for Complex Cyber-Physical Systems: Insigh...
Testing and Development Challenges for Complex Cyber-Physical Systems: Insigh...Testing and Development Challenges for Complex Cyber-Physical Systems: Insigh...
Testing and Development Challenges for Complex Cyber-Physical Systems: Insigh...Sebastiano Panichella
 
Sunlight Spectacle 2024 Practical Action Launch Event 2024-04-08
Sunlight Spectacle 2024 Practical Action Launch Event 2024-04-08Sunlight Spectacle 2024 Practical Action Launch Event 2024-04-08
Sunlight Spectacle 2024 Practical Action Launch Event 2024-04-08LloydHelferty
 
GESCO SE Press and Analyst Conference on Financial Results 2024
GESCO SE Press and Analyst Conference on Financial Results 2024GESCO SE Press and Analyst Conference on Financial Results 2024
GESCO SE Press and Analyst Conference on Financial Results 2024GESCO SE
 
General Elections Final Press Noteas per M
General Elections Final Press Noteas per MGeneral Elections Final Press Noteas per M
General Elections Final Press Noteas per MVidyaAdsule1
 

Kürzlich hochgeladen (11)

Understanding Post Production changes (PPC) in Clinical Data Management (CDM)...
Understanding Post Production changes (PPC) in Clinical Data Management (CDM)...Understanding Post Production changes (PPC) in Clinical Data Management (CDM)...
Understanding Post Production changes (PPC) in Clinical Data Management (CDM)...
 
Scootsy Overview Deck - Pan City Delivery
Scootsy Overview Deck - Pan City DeliveryScootsy Overview Deck - Pan City Delivery
Scootsy Overview Deck - Pan City Delivery
 
cse-csp batch4 review-1.1.pptx cyber security
cse-csp batch4 review-1.1.pptx cyber securitycse-csp batch4 review-1.1.pptx cyber security
cse-csp batch4 review-1.1.pptx cyber security
 
Application of GIS in Landslide Disaster Response.pptx
Application of GIS in Landslide Disaster Response.pptxApplication of GIS in Landslide Disaster Response.pptx
Application of GIS in Landslide Disaster Response.pptx
 
Don't Miss Out: Strategies for Making the Most of the Ethena DigitalOpportunity
Don't Miss Out: Strategies for Making the Most of the Ethena DigitalOpportunityDon't Miss Out: Strategies for Making the Most of the Ethena DigitalOpportunity
Don't Miss Out: Strategies for Making the Most of the Ethena DigitalOpportunity
 
Testing with Fewer Resources: Toward Adaptive Approaches for Cost-effective ...
Testing with Fewer Resources:  Toward Adaptive Approaches for Cost-effective ...Testing with Fewer Resources:  Toward Adaptive Approaches for Cost-effective ...
Testing with Fewer Resources: Toward Adaptive Approaches for Cost-effective ...
 
05.02 MMC - Assignment 4 - Image Attribution Lovepreet.pptx
05.02 MMC - Assignment 4 - Image Attribution Lovepreet.pptx05.02 MMC - Assignment 4 - Image Attribution Lovepreet.pptx
05.02 MMC - Assignment 4 - Image Attribution Lovepreet.pptx
 
Testing and Development Challenges for Complex Cyber-Physical Systems: Insigh...
Testing and Development Challenges for Complex Cyber-Physical Systems: Insigh...Testing and Development Challenges for Complex Cyber-Physical Systems: Insigh...
Testing and Development Challenges for Complex Cyber-Physical Systems: Insigh...
 
Sunlight Spectacle 2024 Practical Action Launch Event 2024-04-08
Sunlight Spectacle 2024 Practical Action Launch Event 2024-04-08Sunlight Spectacle 2024 Practical Action Launch Event 2024-04-08
Sunlight Spectacle 2024 Practical Action Launch Event 2024-04-08
 
GESCO SE Press and Analyst Conference on Financial Results 2024
GESCO SE Press and Analyst Conference on Financial Results 2024GESCO SE Press and Analyst Conference on Financial Results 2024
GESCO SE Press and Analyst Conference on Financial Results 2024
 
General Elections Final Press Noteas per M
General Elections Final Press Noteas per MGeneral Elections Final Press Noteas per M
General Elections Final Press Noteas per M
 

Role of QC and QA in Pharma Industry

  • 1. Role of Q.C & Q.A in Pharmaceutical IndustryRole of Q.C & Q.A in Pharmaceutical Industry PresentedPresented ByBy Rezowanul HaqueRezowanul Haque PharmacistPharmacist Daffodil Internation al UniversityDaffodil Internation al University BangladeshBangladesh
  • 2. QC Roles Evaluation of quality throughout process: Raw materials and API Drug Product Packaging components Reassay Retains
  • 4. Raw Materials All Raw Materials are tested on site before use Incoming identity Full release testing Includes Excipients, Capsules, API Various techniques Raman and IR Spectroscopy Assay (HPLC and Titration) Physical Tests
  • 5. Packaging Components All packaging components tested if in contact with drug product Bottles Blister pack components Cotton wool, Desiccants Range of techniques Appearance Spectroscopy Loss on Drying
  • 6. Finished Product (Release) Release into Clinic Mainly 2 techniques HPLC Dissolution Several tests Assay Content Uniformity Dissolution
  • 7. Finished Product (Reassay) Scheduled reassessment of released drugs Ensures continued efficacy Same techniques as Release HPLC, Dissolution Reduced testing for reassay Reassay schedule drug dependant Comparators –manufacturers expiry In house drugs –decided by formulator
  • 8. Retains  Sample of everything tested retained  Enough for full testing in duplicate  At label conditions  Retain time determined by regulatory guidelines  Raw materials 12 Years  Finished products 10 Years  All unsealed finished products inspected annually
  • 9. Cleaning Verification All manufacturing equipment cleaned Subject Exposure Limit (SEL) set SEL converted to a Residue Limit (RL) Equipment swabbed Tested using HPLC  Std concentration made to RL  Swab concentration must be lower than std All surfaces must be validated
  • 10. Future Process Analytical Technology Paperless laboratory Explore new uses of analytical techniques NIR IMS
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.